Olaf H. Klungel

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 109 citations · Full text

Medicine, Pharmacology, Gene Therapy +14

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman et al. · Cytotherapy · 2020 · 67 citations · Full text

Engineering, Biomedical Engineering, Manufacturing Engineering +17

Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

Simone J. P. M. Eussen, Olaf H. Klungel, Johan Garssen et al. · British Journal Of Nutrition · 2010 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting ??-hydroxy-??-methylglutaryl coenzyme A reductase inhibitor therapy in men

Anke H. Maitland‐van der Zee, Olaf H. Klungel, Bruno HCh Stricker et al. · Pharmacogenetics · 2003 · 22 citations

Pharmacy, Pharmacoeconomics, Pharmacology +17

Functional foods: the case for closer evaluation

Nynke de Jong, Olaf H. Klungel, Hans Verhagen et al. · BMJ · 2007 · 18 citations · Full text

Agriculture, Food Science, Food Policy +9